Search Filters
Use this area to filter your search results. Each filter option allows for multiple selections.
NEW! NEW!
Mercer Allergy & Pulmonary Associates, LLC
Trenton, New Jersey
New Jersey Department of Children and Families
Trenton, New Jersey
CommonSpirit Health Research Institute
San Luis Obispo, California
NEW! NEW!
Akron Children's - Physician Recruitment
Boardman, Ohio
NEW! NEW!
NEW! NEW!
NEW! NEW!
Akron Children's - Physician Recruitment
Massillon, Ohio
NEW! NEW!
NEW! NEW!
NEW! NEW!
NEW! NEW!
Akron Children's - Physician Recruitment
Warren, Ohio
NEW! NEW!
Duke University Health System
Durham, North Carolina
NEW! NEW!
Memorial Sloan Kettering Cancer Center
New York, New York
NEW! NEW!
Akron Children's - Physician Recruitment
Ashland, Ohio
NEW! NEW!
Akron Children's - Physician Recruitment
Akron, Ohio
NEW! NEW!
NEW! NEW!
Loading... Please wait.
Director of Clinical Operations
Alzheon is a clinical-stage biopharmaceutical company committed to developing innovative medicines by directly addressing the underlying pathology of devastating illnesses, such as Alzheimer’s disease (AD) and other neurodegenerative disorders characterized by accumulation of toxic, misfolded proteins. Our lead Alzheimer’s clinical candidate, ALZ-801, is a unique oral, amyloid anti-oligomer agent entering Phase 3 for the treatment of Early AD patients with two copies of the ε4 allele of the apolipoprotein E gene (APOE4/4). Building on seven years of research in amyloid oligomer biology, and an evidence foundation of 2000 patients treated with the active ingredient of ALZ-801, Alzheon scientists have found a better way to block the harmful effects of brain proteins called soluble amyloi
Loading. Please wait.